Publications Prof Golo Ahlenstiel
Prof Ahlenstiel has published widely in the medical literature and continues to be active in teaching and research.
Summaries of research output can be found on:
Publications are listed below by topic.
The effectiveness of rifabutin triple therapy for patients with difficult-to-eradicate Helicobacter pylori in clinical practice.
van der Poorten D, Katelaris P.
Aliment Pharmacol Ther. 2007 Dec;26(11-12):1537-42. Epub 2007 Sep 28. Impact factor 3.71
Feasibility and safety of overtubes for PEG-tube placement in patients with head and neck cancer.
Musumba CO, Hsu J, Ahlenstiel G, Tutticci NJ, Nanda KS, van der Poorten D, Lee EY, Kwan V. Gastroenterol Res Pract. 2015;2015:612610.
Levodopa-carbidopa intestinal gel infusion improves motor performance and quality of life in patients with advanced Parkinson’s disease.
Florence Ching-Fen Chang, Vu Kwan, D Van der Poorten, Neil Mahant, Nigel Wolfe, Ainhi Ha, Jane Griffith, David Tsui, Samuel Kim, Victor SC Fung. Journal of Clinical Neuroscience 2014, 21 (11), 2033
Compounded levofloxacin triple therapy for treatment resistant Helicobacter Pylori.
V Gupta, SN Loch, D Van der Poorten.
J Gastro Hep. 2014 Oct; 29, 138-138
Klein A, Ahlenstiel G, Tate DJ, Burgess N, Richardson A, Pang T, Byth K, Bourke MJ.
Endoscopy. 2017 Apr 4. doi: 10.1055/s-0043-105484. [Epub ahead of print]
O'Connor KS, Read SA, Wang M, Schibeci S, Eslam M, Ong A, Weltman MD, Douglas MW, Mazzola A, Craxì A, Petta S, Stewart GJ, Liddle C, George J, Ahlenstiel G, Booth DR.
Genes Immun. 2016 Sep;17(6):328-34. doi: 10.1038/gene.2016.27. Epub 2016 Jun 16.
Validated computed cleansing score for video capsule endoscopy.
Klein A, Gizbar M, Bourke MJ, Ahlenstiel G.
Dig Endosc. 2016 Jul;28(5):564-9. doi: 10.1111/den.12599. Epub 2016 Jan 21.
FibroGENE: A gene-based model for staging liver fibrosis.
Eslam M, Hashem AM, Romero-Gomez M, Berg T, Dore GJ, Mangia A, Chan HL, Irving WL, Sheridan D, Abate ML, Adams LA, Weltman M, Bugianesi E, Spengler U, Shaker O, Fischer J, Mollison L, Cheng W, Nattermann J, Riordan S, Miele L, Kelaeng KS, Ampuero J, Ahlenstiel G, McLeod D, Powell E, Liddle C, Douglas MW, Booth DR, George J; International Liver Disease Genetics Consortium (ILDGC)..
J Hepatol. 2016 Feb;64(2):390-8. doi: 10.1016/j.jhep.2015.11.008. Epub 2015 Dec 1.
Garcia MC, Ahlenstiel G, Mahajan H, van der Poorten D.
J Med Case Rep. 2015 Oct 1;9:210. doi: 10.1186/s13256-015-0705-6.
Dold L, Ahlenstiel G, Althausen E, Luda C, Schwarze-Zander C, Boesecke C, Wasmuth JC, Rockstroh JK, Spengler U.
PLoS One. 2015 Aug 4;10(8):e0134158. doi: 10.1371/journal.pone.0134158. eCollection 2015.
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease.
Eslam M, Hashem AM, Leung R, Romero-Gomez M, Berg T, Dore GJ, Chan HL, Irving WL, Sheridan D, Abate ML, Adams LA, Mangia A, Weltman M, Bugianesi E, Spengler U, Shaker O, Fischer J, Mollison L, Cheng W, Powell E, Nattermann J, Riordan S, McLeod D, Armstrong NJ, Douglas MW, Liddle C, Booth DR, George J, Ahlenstiel G; International Hepatitis C Genetics Consortium (IHCGC)..
Nat Commun. 2015 Mar 5;6:6422. doi: 10.1038/ncomms7422.
Feasibility and Safety of Overtubes for PEG-Tube Placement in Patients with Head and Neck Cancer.
Musumba CO, Hsu J, Ahlenstiel G, Tutticci NJ, Nanda KS, van der Poorten D, Lee EY, Kwan V.
Gastroenterol Res Pract. 2015;2015:612610. doi: 10.1155/2015/612610. Epub 2015 Apr 21.
Dendritic cells in hepatitis C virus infection: key players in the IFNL3-genotype response.
O'Connor KS, George J, Booth D, Ahlenstiel G.
World J Gastroenterol. 2014 Dec 21;20(47):17830-8. doi: 10.3748/wjg.v20.i47.17830. Review.
Ahlenstiel G, Hourigan LF, Brown G, Zanati S, Williams SJ, Singh R, Moss A, Sonson R, Bourke MJ; Australian Colonic Endoscopic Mucosal Resection (ACE) Study Group..
Gastrointest Endosc. 2014 Oct;80(4):668-76. doi: 10.1016/j.gie.2014.04.015. Epub 2014 Jun 7.
Werner JM, Serti E, Chepa-Lotrea X, Stoltzfus J, Ahlenstiel G, Noureddin M, Feld JJ, Liang TJ, Rotman Y, Rehermann B.
Hepatology. 2014 Oct;60(4):1160-9. doi: 10.1002/hep.27092. Epub 2014 Aug 13.
O'Connor KS, Ahlenstiel G, Suppiah V, Schibeci S, Ong A, Leung R, van der Poorten D, Douglas MW, Weltman MD, Stewart GJ, Liddle C, George J, Booth DR.
Innate Immun. 2014 Aug;20(6):598-605. doi: 10.1177/1753425913503385. Epub 2013 Sep 17.
IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection.
Eslam M, Leung R, Romero-Gomez M, Mangia A, Irving WL, Sheridan D, Spengler U, Mollison L, Cheng W, Bugianesi E, McLeod D, Zaitoun AM, Attino V, Goeltz D, Nattermann J, Douglas M, Booth DR, George J, Ahlenstiel G.
J Hepatol. 2014 Aug;61(2):235-41. doi: 10.1016/j.jhep.2014.03.039. Epub 2014 Apr 24.
A summary of the 20th International Symposium on Hepatitis C Virus and Related Viruses.
Beard MR, Ffrench R, Gowans EJ, Helbig KJ, Eyre NM, Douglas MM, Grebely J, Ahlenstiel G, Locarnini S, George J, Shackel NA, White PA, Thompson AJ, Drummer HE.
Gastroenterology. 2014 Jul;147(1):e1-4. doi: 10.1053/j.gastro.2014.05.022. Epub 2014 May 23. No abstract available.
Eslam M, Booth DR, George J, Ahlenstiel G.
World J Gastroenterol. 2013 Nov 7;19(41):7055-61. doi: 10.3748/wjg.v19.i41.7055.
PMID:
The natural killer cell response to HCV infection.
Ahlenstiel G.
Immune Netw. 2013 Oct;13(5):168-76. doi: 10.4110/in.2013.13.5.168. Epub 2013 Oct 26. Review.
Suppiah V, Armstrong NJ, O'Connor KS, Berg T, Weltman M, Abate ML, Spengler U, Bassendine M, Dore GJ, Irving WL, Powell E, Nattermann J, Mueller T, Riordan S, Stewart GJ, George J, Booth DR, Ahlenstiel G; International Hepatitis C Genetics Consortium (IHCGC)..
Genes Immun. 2013 Jul-Aug;14(5):286-90. doi: 10.1038/gene.2013.15. Epub 2013 Apr 18.
Pharmacogenomics of hepatitis C infections: personalizing therapy.
Booth DR, Ahlenstiel G, George J.
Genome Med. 2012 Dec 26;4(12):99. doi: 10.1186/gm400. eCollection 2012. Review.
Will IL28B polymorphisms remain relevant to direct-acting antiviral treatment paradigms?
Ahlenstiel G, Booth DR, George J.
Antivir Ther. 2012;17(6 Pt B):1163-70. doi: 10.3851/IMP2427. Epub 2012 Oct 5. Review.
Edlich B, Ahlenstiel G, Zabaleta Azpiroz A, Stoltzfus J, Noureddin M, Serti E, Feld JJ, Liang TJ, Rotman Y, Rehermann B.
Hepatology. 2012 Jan;55(1):39-48. doi: 10.1002/hep.24628. Epub 2011 Nov 14.
Ahlenstiel G, Edlich B, Hogdal LJ, Rotman Y, Noureddin M, Feld JJ, Holz LE, Titerence RH, Liang TJ, Rehermann B.
Gastroenterology. 2011 Oct;141(4):1231-9, 1239.e1-2. doi: 10.1053/j.gastro.2011.06.069. Epub 2011 Jul 7.
Suppiah V, Gaudieri S, Armstrong NJ, O'Connor KS, Berg T, Weltman M, Abate ML, Spengler U, Bassendine M, Dore GJ, Irving WL, Powell E, Hellard M, Riordan S, Matthews G, Sheridan D, Nattermann J, Smedile A, Müller T, Hammond E, Dunn D, Negro F, Bochud PY, Mallal S, Ahlenstiel G, Stewart GJ, George J, Booth DR; International Hepatitis C Genetics Consortium (IHCGC)..
PLoS Med. 2011 Sep;8(9):e1001092. doi: 10.1371/journal.pmed.1001092. Epub 2011 Sep 13.
Smith KR, Suppiah V, O'Connor K, Berg T, Weltman M, Abate ML, Spengler U, Bassendine M, Matthews G, Irving WL, Powell E, Riordan S, Ahlenstiel G, Stewart GJ, Bahlo M, George J, Booth DR; International Hepatitis C Genetics Consortium (IHCGC)..
Genome Med. 2011 Aug 31;3(8):57. doi: 10.1186/gm273.
Feld JJ, Modi AA, El-Diwany R, Rotman Y, Thomas E, Ahlenstiel G, Titerence R, Koh C, Cherepanov V, Heller T, Ghany MG, Park Y, Hoofnagle JH, Liang TJ.
Gastroenterology. 2011 Mar;140(3):830-9. doi: 10.1053/j.gastro.2010.09.010. Epub 2010 Sep 17.
IL28B in hepatitis C virus infection: translating pharmacogenomics into clinical practice.
Ahlenstiel G, Booth DR, George J.
J Gastroenterol. 2010 Sep;45(9):903-10. doi: 10.1007/s00535-010-0287-4. Epub 2010 Jul 16. Review.
Vogel M, Ahlenstiel G, Hintsche B, Fenske S, Trein A, Lutz T, Schürmann D, Stephan C, Khaykin P, Bickel M, Mayr C, Baumgarten A, Buggisch P, Klinker H, John C, Gölz J, Staszewski S, Rockstroh JK.
Eur J Med Res. 2010 Mar 30;15(3):102-11.
Ahlenstiel G, Titerence RH, Koh C, Edlich B, Feld JJ, Rotman Y, Ghany MG, Hoofnagle JH, Liang TJ, Heller T, Rehermann B.
Gastroenterology. 2010 Jan;138(1):325-35.e1-2. doi: 10.1053/j.gastro.2009.08.066. Epub 2009 Sep 10.
IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.
Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, Bassendine M, Spengler U, Dore GJ, Powell E, Riordan S, Sheridan D, Smedile A, Fragomeli V, Müller T, Bahlo M, Stewart GJ, Booth DR, George J.
Nat Genet. 2009 Oct;41(10):1100-4. doi: 10.1038/ng.447. Epub 2009 Sep 13.
Mas Marques A, Mueller T, Welke J, Taube S, Sarrazin C, Wiese M, Halangk J, Witt H, Ahlenstiel G, Spengler U, Goebel U, Schott E, Weich V, Schlosser B, Wasmuth HE, Lammert F, Berg T, Schreier E.
Infect Genet Evol. 2009 Sep;9(5):847-52. doi: 10.1016/j.meegid.2009.05.002. Epub 2009 May 14.
Mix H, Weiler-Normann C, Thimme R, Ahlenstiel G, Shin EC, Herkel J, David CS, Lohse AW, Rehermann B.
Gastroenterology. 2008 Dec;135(6):2107-18. doi: 10.1053/j.gastro.2008.07.029. Epub 2008 Jul 31.
Nattermann J, Vogel M, Nischalke HD, Danta M, Ahlenstiel G, Michalk M, Sauerbruch T, Rockstroh JK, Spengler U; Kompetenznetz HIV/AIDS..
AIDS. 2008 Jul 11;22(11):1287-92. doi: 10.1097/QAD.0b013e3282f85daa.
Caggiari L, De Zorzi M, Ahlenstiel G, Rehermann B, De Re V.
Tissue Antigens. 2008 Jul;72(1):79-83. doi: 10.1111/j.1399-0039.2008.01061.x. Epub 2008 May 20.
De Zorzi M, Caggiari L, Ahlenstiel G, Rehermann B, De Re V.
Tissue Antigens. 2008 May;71(5):490-2. doi: 10.1111/j.1399-0039.2008.01027.x. Epub 2008 Mar 11.
Ahlenstiel G, Martin MP, Gao X, Carrington M, Rehermann B.
J Clin Invest. 2008 Mar;118(3):1017-26. doi: 10.1172/JCI32400.
Ahlenstiel G, Roomp K, Däumer M, Nattermann J, Vogel M, Rockstroh JK, Beerenwinkel N, Kaiser R, Nischalke HD, Sauerbruch T, Lengauer T, Spengler U; Kompetenznetz HIV/AIDS..
Clin Vaccine Immunol. 2007 Oct;14(10):1266-73. Epub 2007 Aug 22.
Ahlenstiel G, Nischalke HD, Bueren K, Berg T, Vogel M, Biermer M, Grünhage F, Sauerbruch T, Rockstroh J, Spengler U, Nattermann J.
J Hepatol. 2007 Sep;47(3):348-55. Epub 2007 May 24.
Vogel M, Lichterfeld M, Kaufmann DE, Mui SK, Altfeld M, Voigt E, Ahlenstiel G, Kupfer B, Walker B, Spengler U, Rockstroh JK.
Eur J Med Res. 2006 Jul 31;11(7):273-8.
Ahlenstiel G, Iwan A, Nattermann J, Bueren K, Rockstroh JK, Brackmann HH, Kupfer B, Landt O, Peled A, Sauerbruch T, Spengler U, Woitas RP.
World J Gastroenterol. 2005 Dec 28;11(48):7631-8.
Hepatitis C virus and the threshold of natural killer cell inhibition.
Ahlenstiel G, Rehermann B.
Hepatology. 2005 Mar;41(3):675-7. No abstract available.
Nattermann J, Nischalke HD, Hofmeister V, Ahlenstiel G, Zimmermann H, Leifeld L, Weiss EH, Sauerbruch T, Spengler U.
Am J Pathol. 2005 Feb;166(2):443-53.
Nattermann J, Nischalke HD, Hofmeister V, Kupfer B, Ahlenstiel G, Feldmann G, Rockstroh J, Weiss EH, Sauerbruch T, Spengler U.
Antivir Ther. 2005;10(1):95-107.
Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5.
Nattermann J, Nischalke HD, Feldmann G, Ahlenstiel G, Sauerbruch T, Spengler U.
J Viral Hepat. 2004 Nov;11(6):519-26.
Mueller T, Mas-Marques A, Sarrazin C, Wiese M, Halangk J, Witt H, Ahlenstiel G, Spengler U, Goebel U, Wiedenmann B, Schreier E, Berg T.
J Hepatol. 2004 Oct;41(4):652-8.
CC-chemokine receptor 5 (CCR5) in hepatitis C--at the crossroads of the antiviral immune response?
Ahlenstiel G, Woitas RP, Rockstroh J, Spengler U.
J Antimicrob Chemother. 2004 Jun;53(6):895-8. Epub 2004 May 5.
Effects of the CCR5-Delta32 mutation on antiviral treatment in chronic hepatitis C.
Ahlenstiel G, Berg T, Woitas RP, Grünhage F, Iwan A, Hess L, Brackmann HH, Kupfer B, Schernick A, Sauerbruch T, Spengler U.
J Hepatol. 2003 Aug;39(2):245-52.
Woitas RP, Ahlenstiel G, Iwan A, Rockstroh JK, Brackmann HH, Kupfer B, Matz B, Offergeld R, Sauerbruch T, Spengler U.
Dtsch Med Wochenschr. 2002 Sep 6;127(36):1807-12. German.
Woitas RP, Ahlenstiel G, Iwan A, Rockstroh JK, Brackmann HH, Kupfer B, Matz B, Offergeld R, Sauerbruch T, Spengler U.
Gastroenterology. 2002 Jun;122(7):1721-8.